Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular

Mayra Guerrero1, Marina Urena, Amit Pursnani

  • 1Division of Cardiology, Evanston Hospital, North Shore University Health System, Evanston, IL, USA - mayraguerrero@icloud.com.

Insights

Transcatheter mitral valve replacement (TMVR) offers a potential alternative for high-risk patients with severe mitral annular calcification (MAC). Early results show promise, but careful patient selection and imaging are crucial for success.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Mitral annular calcification (MAC) presents significant surgical risks for mitral valve replacement due to comorbidities and anatomical challenges.
  • Many patients with severe MAC are inoperable with conventional surgical approaches.
  • Transcatheter mitral valve replacement (TMVR) using balloon-expandable aortic valves has emerged as a compassionate use option.

Purpose of the Study:

  • To review the early clinical experience with transcatheter mitral valve replacement (TMVR) in patients with severe mitral annular calcification (MAC).
  • To summarize reported successes and failures of this emerging transcatheter therapy.
  • To assess the potential of TMVR as an alternative to surgery for high-risk MAC patients.

Main Methods:

  • Literature review of early TMVR cases in patients with severe MAC.
  • Analysis of reported procedural outcomes, including successes and complications.
  • Evaluation of the role of multimodality imaging in patient selection and risk assessment.

Main Results:

  • TMVR shows potential as an alternative for selected inoperable MAC patients.
  • The field is nascent, with progress expected to be slower than transcatheter aortic valve replacement due to mitral valve complexity.
  • Left ventricular outflow tract (LVOT) obstruction is a key complication requiring optimized patient selection and management strategies.

Conclusions:

  • TMVR may become an acceptable option for carefully selected severe MAC patients unsuitable for surgery.
  • Multimodality imaging is essential for accurate annular sizing and LVOT obstruction risk assessment.
  • Optimizing candidate selection, avoiding end-stage disease patients, and developing LVOT obstruction management are key to improving outcomes.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
426
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
518
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
402
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.0K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
359